Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia

Laboratory Investigation

Volumn 88, Issue 10, 2008, Pages 1057-1067

  Guller, Seth ^a   Buhimschi, Catalin S ^a   Ma, Yula Y ^a   Huang, Se Te J ^a   Yang, Liubin ^a   Kuczynski, Edward ^a   Zambrano, Eduardo ^a   Lockwood, Charles J ^a   Buhimschi, Irina A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ceruloplasmin; Hypoxia; Oxygen radicals; Placenta; Preeclampsia

Indexed keywords

CARRIER PROTEIN; CERULOPLASMIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; DISEASE SEVERITY; DNA FINGERPRINTING; DNA MICROARRAY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; SYNCYTIOTROPHOBLAST; SYNCYTIUM; TERM BIRTH; UPREGULATION; WESTERN BLOTTING;

ADULT; ANOXIA; CASE-CONTROL STUDIES; CELLS, CULTURED; CERULOPLASMIN; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RNA, MESSENGER; TROPHOBLASTS; UP-REGULATION;

EID: 52649163807     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.74     Document Type: Article

References (59)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594.
2. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1-7.
3. Stepan H, Faber R, Dornhofer N, et al. New insights into the biology of preeclampsia. Biol Reprod 2006;74:772-776.
4. Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289-1296.
5. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004;122:369-382.
6. Sikkema JM, van Rijn BB, Franx A, et al. Placental superoxide is increased in pre-eclampsia. Placenta 2001;22:304-308.
7. Benyo DF, Smarason A, Redman CW, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86:2505-2512.
8. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40:102-111.
9. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27:56-61.
10. Knight M, Redman CW, Linton EA, et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 1998;105:632-640.
11. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
12. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-649.
13. Estelles A, Gilabert J, Keeton M, et al. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 1994;84:143-150.
14. Many A, Hubel CA, Fisher SJ, et al. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000;156:321-331.
15. Myatt L, Rosenfield RB, Eis AL, et al. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996;28:488-493.
16. Soleymanlou N, Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 2005;90:4299-4308.
17. Meade ES, Ma YY, Guller S. Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line. Placenta 2007;28:1012-1019.
18. Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004;145:4838-4845.
19. Yinon Y, Nevo O, Xu J, et al. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor- 3. Am J Pathol 2008;172:77-85.
20. Cester N, Staffolani R, Rabini RA, et al. Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem 1994;131:151-155.
21. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996;3:179-184.
22. Knapen MF, Peters WH, Mulder TP, et al. Glutathione and glutathione-related enzymes in decidua and placenta of controls and women with pre-eclampsia. Placenta 1999;20:541-546.
23. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002;22:439-458.
24. Patel BN, Dunn RJ, Jeong SY, et al. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 2002;22:6578-6586.
25. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002 Obstet Gynecol 2002;99:159-167.
26. Buhimschi CS, Norwitz ER, Funai E, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005;192:734-741.
27. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-418.
28. Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol 2005;32:571-600.
29. Pettker CM, Buhimschi IA, Magloire LK, et al. Value of placental microbial evaluation in diagnosing intra-amniotic infection. Obstet Gynecol 2007;109:739-749.
30. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989;73:383-389.
31. Huang SJ, Schatz F, Masch R, et al. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol 2006;72:60-73.
32. Ma Y, Krikun G, Abrahams VM, et al. Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection. Placenta 2007;28:1024-1031.
33. Lee MJ, Wang Z, Yee H, et al. Expression and regulation of glucocorticoid receptor in human placental villous fibroblasts. Endocrinology 2005;146:4619-4626.
34. Guller S, LaCroix NC, Kirkun G, et al. Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts. J Steroid Biochem Mol Biol 1993;46:1-10.
35. Kliman HJ, Nestler JE, Sermasi E, et al. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986;118:1567-1582.
36. Fant ME, Nanu L. Human placental endothelin: expression of endothelin-1 mRNA by human placental fibroblasts in culture. Mol Cell Endocrinol 1995;109:119-123.
37. Danzeisen R, Fosset C, Chariana Z, et al. Placental ceruloplasmin homolog is regulated by iron and copper and is implicated in iron metabolism. Am J Physiol Cell Physiol 2002;282:C472-C478.
38. Danzeisen R, Ponnambalam S, Lea RG, et al. The effect of ceruloplasmin on iron release from placental (BeWo) cells; evidence for an endogenous Cu oxidase. Placenta 2000;21:805-812.
39. Price ER, Zydowsky LD, Jin MJ, et al. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci USA 1991;88:1903-1907.
40. Scheinberg IH, Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952;116:484-485.
41. Lee GR, Nacht S, Lukens JN, et al. Iron metabolism in copper-deficient swine. J Clin Invest 1968;47:2058-2069.
42. Roeser HP, Lee GR, Nacht S, et al. The role of ceruloplasmin in iron metabolism. J Clin Invest 1970;49:2408-2417.
43. Osaki S, Johnson DA, Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem 1971;246:3018-3023.
44. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966;241:2746-2751.
45. Barber EF, Cousins RJ. Interleukin-1 - stimulated induction of ceruloplasmin synthesis in normal and copper-deficient rats. J Nutr 1988;118:375-381.
46. Gitlin JD. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem 1988;263:6281-6287.
47. Sarkar J, Seshadri V, Tripoulas NA, et al. Role of ceruloplasmin in macrophage iron efflux during hypoxia. J Biol Chem 2003;278:44018-44024.
48. Aldred AR, Grimes A, Schreiber G, et al. Rat ceruloplasmin. Molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J Biol Chem 1987;262:2875-2878.
49. Fleming RE, Gitlin JD. Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem 1990;265:7701-7707.
50. Fortna RR, Watson HA, Nyquist SE. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol Reprod 1999;61:1042-1049.
51. Patel BN, David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 1997;272:20185-20190.
52. Yang FM, Friedrichs WE, Cupples RL, et al. Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing. J Biol Chem 1990;265:10780-10785.
53. Engin-Ustun Y, Ustun Y, Kamaci M, et al. Maternal serum ceruloplasmin in preeclampsia. Int J Gynaecol Obstet 2005;89:51-52.
54. Galinier A, Periquet B, Lambert W, et al. Reference range for micronutrients and nutritional marker proteins in cord blood of neonates appropriated for gestational ages. Early Hum Dev 2005;81:583-593.
55. Serdar Z, Gur E, Develioglu O. Serum iron and copper status and oxidative stress in severe and mild preeclampsia. Cell Biochem Funct 2006;24:209-215.
56. Fitzpatrick TE, Graham CH. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 1998;245:155-162.
57. Hansson SR, Chen Y, Brodszki J, et al. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 2006;12:169-179.
58. Reimer T, Koczan D, Gerber B, et al. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 2002;8:674-680.
59. Zhou R, Zhu Q, Wang Y, et al. Genomewide oligonucleotide microarray analysis on placentae of pre-eclamptic pregnancies. Gynecol Obstet Invest 2006;62:108-114.